Add-on Simvastatin in Schizophrenia Trial.

Trial Profile

Add-on Simvastatin in Schizophrenia Trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Simvastatin (Primary) ; Antipsychotics
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms ASSIST
  • Most Recent Events

    • 27 Apr 2012 Actual patient number 23 added as reported by ClinicalTrials.gov.
    • 27 Apr 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 14 Jul 2011 Planned End Date changed from 1 Apr 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top